The anti-viral to treat coronavirus positive patients has been developed, Pharmaceutical manufacturer Strides Pharma Science said on Wednesday, adding the drug has demonstrated positive outcomes on COVID-19 positive patients so far. Officially called 'Favipiravir', the drug is believed to have proven to reduce the duration of coronavirus infection among patients. It has also resulted in the improvement of patients suffering from lung infections, Strides Pharma Science said. from IndiaTV Business: Google News Feed https://ift.tt/2W9Y8I9
0 Comments